Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration

All-trans-retinoic acid (ATRA) is the standard of care for the management of acute promyelocytic leukemia (APL), but can be associated with differentiation syndrome (DS). Over a seven-year period, we sought to determine the impact of ATRA initiation time on the development of DS. ATRA administration...

Descripción completa

Detalles Bibliográficos
Autores principales: Nauffal, Mary, Werner, Lillian, Ni, Jian, Stone, Richard M., DeAngelo, Daniel J., McDonnell, Anne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904816/
https://www.ncbi.nlm.nih.gov/pubmed/31867205
http://dx.doi.org/10.1016/j.lrr.2019.100189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904816/
https://www.ncbi.nlm.nih.gov/pubmed/31867205
http://dx.doi.org/10.1016/j.lrr.2019.100189

Ejemplares similares